All patients | Pt. with eGFR≥45 | Pt. with eGFR< 45 | p | |
---|---|---|---|---|
n | 189 | 116 | 73 | |
Male sex, n (%) | 116 (61.4) | 74 (63.8) | 42 (57.5) | 0.18 |
Mean age (years) | 73.4 ± 7.9 | 72.1 ± 8.0 | 75.9 ± 6.7 | 0.10 |
BMI (kg/m2) | 29.3 ± 5.4 | 28.94 ± 5.5 | 29.28 ± 5.2 | 0.83 |
BSA (m2) | 1.96 ± 0.23 | 1.96 ± 0.20 | 1.95 ± 0.24 | 0.58 |
CHA2DS2-VASc score | 3.88 ± 1.6 | 3.40 ± 1.57 | 4.50 ± 1.42 | < 0.01 |
HAS-BLED – Score | 3.35 ± 1.0 | 3.13 ± 0.9 | 3.65 ± 1.0 | < 0.01 |
Arterial hypertension, n (%) | 164 (86.8) | 98 (84.5) | 66 (90.4) | 0.32 |
Diabetes mellitus, n (%) | 85 (45.0) | 40 (34.5) | 45 (61.6) | < 0.01 |
Hyperlipidaemia, n (%) | 94 (49.7) | 56 (48.3) | 38 (52.1) | 0.42 |
Smoking status | ||||
non-smoker, n (%) | 138 (73.0) | 81 (69.8) | 57 (78.1) | 0.12 |
smoker, n (%) | 25 (13.2) | 15 (12.9) | 10 (13.7) | 0.70 |
stopped smoking, n (%) | 26 (13.8) | 20 (17.2) | 6 (8.2) | 0.10 |
Atrial fibrillation | ||||
paroxysmal, n (%) | 75 (39.7) | 48 (41.4) | 27 (37.0) | 0.33 |
pers./perm., n (%) | 114 (60.3) | 68 (58.6) | 46 (63.0) | |
Previous stroke / TIA, n (%) | 33 (17.2) | 21 (17.5) | 12 (16.4) | 0.80 |